340B program represents 6% or more of US pharma market
Purchases totaled $19.3 billion, up 19% over 2016, say Drug Channels' Adam Fein
Mark Merritt will leave PCMA leadership at year-end
Move comes as drug pricing policies get heightened attention in Washington
How about a free, open-source, DSCSA-compliant traceability system?
Vantage Consulting Group lends support to the Qu4rtet open-source effort
EMD Serono Specialty Digest shows more interest in site of care by payers
14th edition attracted 59 commercial plans as respondents, representing 100 million lives
Asembia expands its hub services offerings
Company celebrates its growth at annual industry event
Online personal data will be a boon for patient support
Specialty-pharma support providers have a potential benefit in behavioral targeting insights
PBMs' copay ‘accumulator’ programs are a rising threat to pharma’s support of patient reimbursement, says TrialCard
Company offers a risk-mitigation analytics suite to enable pharma monitoring
Nominal drug spending hit $452.6 billion in the US in 2017, says IQVIA
While nominal spending was up 1.4%, actual net spending was only 0.6% greater than 2016
The contract research market: revenues are growing while vendors are consolidating
Projected growth rates for outsourced work range from 12 to 17%
American Cryostem licenses its collection, processing and storage technology for cell therapy
Proprietary processes combine cryogenic and room-temperature steps for adipose tissue
Moving the needle in pediatric and adult vaccines
Vaccines for adult disease states and for tropical diseases expand the market beyond traditional pediatric applications
Molecular tagging of oral solids offers drug authentication
Colorcon will partner with Applied DNA Sciences for pill-coating taggants
McKesson Specialty Health integrates CoverMyMeds ePA access
Speed to therapy is a benefit
Allogene Therapeutics, a new biotech, launches with an alternative CAR-T technology
So-called ‘off the shelf’ CAR-T treatments could change the field just as first products enter commercialization
Pharma goes deeper into blockchain development
Supply chain security—with DSCSA compliance—could be a near-term use case, says Accenture
Veeva-sponsored consortium to develop standards for CRO data exchange
Align Clinical CRO will streamline clinical-study data processes
Amazon is already affecting pharma supply chains—and not necessarily for the better
Pharma logistics gathering highlights supply bottlenecks
A ‘startling’ lack of DSCSA preparedness, says TraceLink survey
The November 2018 deadlines for all-serialized product is looming
Patient Support Vendor Directory 2018
Getting at the value of value-based drug pricing models
Existing ‘pay for performance’ models do not scale up well yet
The Hub Services Wheel keeps Rolling Along
Patient support (hub) services rise in lockstep with specialty pharmaceutical launches
Improving Patient Services and Outcomes with Data-Driven Design to Hub Services
Data drawn from collaborating sources can benefit the patient journey
Patient centricity and the growing role of hub services
Hub services enhance relationships with patients
A Conversation with Nitin Sahney, PharmaCord
Global drug spending was $1.135 trillion in 2017, says IQVIA
Forecast is for 3-6% CAGR through 2022
Guidance for VAWD® Accreditation
Learn the steps for becoming a Verified-Accredited Wholesaler Distributor®
Pelican Biothermal introduces a modular bulk shipper
Wide capacity range combines with CRT, refrigerated and frozen shipping
World Courier adds more global offices
Deepens focus on logistics for direct-to-patient, cell and gene therapy and clinical trials execution
Cold storage failures at two fertility clinics highlight the need for better monitoring
Thousands of human eggs and embryos may have been lost; meanwhile, industry research facilities shift to predictive maintenance
Is the proposed Cigna-Express Scripts deal the end of the PBM era?
$67-billion Cigna bid, if permitted, would pull in the last large independent PBM
